Forbes Magazine has a new article (might need a login and password; borrow one here) that highlights a handful of companies that are researching new technologies and developing new products for biodefense, directed against both the terrorism and avian flu threats:
Government funding will likely spur growth in the biosecurity business. In 2004 Congress approved Project BioShield to aid research and development for detecting viruses and biological weapons. Biotech companies have received a fraction of the $5.6 billion, ten-year allocation, but investors are catching a whiff of this new pork from Congress. The $7.1 billion President George W. Bush laid out in November to fight bird flu has led to Senate bills that could result in additional biosensor opportunities.
The article contains some interesting details about key companies working in this sector, describing them as “tempting takeover targets.”